AbbVie Inc (ABBV)

AbbVie Inc (ABBV) is a Drug Manufacturers - General company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $505B; returns 1 day +0.2%, 1 week +0.1%, 1 year +25.1%.

AbbVie is a global biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines. The company's revenue model is based on direct sales of its biopharmaceutical products to healthcare providers, hospitals, and pharmacies worldwide.

Groups ABBV belongs to

• Dividend Payers
• Biopharmaceutical
• S&P 500
• Pharmaceuticals
• Healthcare
• Immunotherapy
• Neuroscience
• Autoimmune Diseases
• Rheumatoid Arthritis
• Biotechnology
• Oncology
• Neurological Disorders

ABBV financial model: income statement, cash flow and balance sheet